Welcome to the Genomics Law Report!
Since the completion of the Human Genome Project nearly a decade ago, technological and scientific progress in the fields of genomics and personalized medicine continues to accelerate, with the next generation of human genomic research seeking to untangle the complex relationship between genes and traits and realize the promise of personalized medicine. As these fields have grown, researchers, entrepreneurs and established companies have all enjoyed increasing public and media attention — along with the attention of politicians, regulators, and judges, who are bringing a new layer of complexity to an already complicated legal and regulatory framework.
To help make sense of the resulting confusion, Robinson, Bradshaw & Hinson proudly announces the launch of the Genomics Law Report. The Genomics Law Report focuses on the legal implications of important developments in the fields of genomics and personalized medicine — including key litigation, legislative, regulatory and policymaking activities — in order to facilitate understanding of the complicated and shifting legal landscape governing genomic and personalized medicine commerce and research.
We hope that the Genomics Law Report will enable you to follow these developments as we see them, from a legal perspective, and encourage the exchange of information and ideas within the genomics and personalized medicine communities.
If you’d like to learn more about the Genomics Law Report, would like to contribute or have a suggestion for what you’d like to see us cover, please feel free to send us a message at genomicslawreport@rbh.com. In the meantime, welcome and thank you!
Hi. I really like the idea behind GLR. I think the crosstalk is something that law practitioners, policymakers, and genome scientists could all benefit from. I’m a budding human geneticist interested in the intellectual property side of things. I would welcome any posts discussing the changing climate in the patent prosecution/litigation arena as new developments rapidly arise in human genomics.
Stephen Turner
http://GettingGeneticsDone.blogspot.com/